Welcome to our dedicated page for Fluent news (Ticker: CNTMF), a resource for investors and traders seeking the latest updates and insights on Fluent stock.
About Fluent Corp (CNTMF)
Fluent Corp (formerly Cansortium Inc.) is a vertically integrated, multi-state cannabis company operating under the renowned FLUENT™ brand. Headquartered in Tampa, Florida, Fluent Corp is dedicated to delivering high-quality cannabis products through its comprehensive value chain, which spans cultivation, production, distribution, and retail. With licenses and operations in Florida, Pennsylvania, Texas, and New York, the company caters to both medical marijuana patients and adult-use consumers, offering a diverse portfolio of premium cannabis products tailored to meet varying needs and preferences.
Core Operations and Business Model
Fluent Corp’s vertically integrated model ensures strict quality control at every stage of its operations. The company oversees the cultivation of cannabis in state-of-the-art facilities, utilizing advanced techniques to optimize product quality and yield. This is followed by in-house production processes that focus on creating a wide range of cannabis products, including flower, concentrates, edibles, tinctures, and cartridges. Fluent’s retail network, which includes dispensaries operating under the FLUENT™ brand, provides a welcoming environment with knowledgeable staff to guide customers in selecting the best products for their needs. Additionally, the company leverages online ordering and express pickup services to enhance customer convenience.
Market Presence and Expansion
Fluent Corp has established a strong foothold in key markets, particularly in Florida, where it operates an extensive network of dispensaries. The company continues to expand its reach, with plans to open new locations and introduce innovative product lines. Recent initiatives include the launch of the Hyer Kind concentrates brand, the MOODS product line tailored to specific experiences, and the KNACK flower brand, which emphasizes locally grown, high-quality cannabis. Fluent’s commitment to scalability is further demonstrated by its strategic business combination with RIV Capital Inc., positioning it as a significant player in the evolving U.S. cannabis industry.
Commitment to Quality and Innovation
Fluent Corp is driven by an unwavering commitment to operational excellence and innovation. The company employs cutting-edge cultivation and extraction techniques to produce premium cannabis products that prioritize flavor, potency, and accessibility. Its product portfolio is designed to cater to a wide range of consumer preferences, from medical patients seeking therapeutic benefits to recreational users exploring curated cannabis experiences. By continuously expanding its offerings and introducing new formats, Fluent ensures it remains at the forefront of industry trends.
Regulatory and Industry Context
Operating within the highly regulated U.S. cannabis market, Fluent Corp navigates complex state and federal laws to deliver compliant and reliable products. While cannabis remains a Schedule I substance under federal law, the company’s adherence to state regulations and its focus on medical and adult-use markets position it as a trusted operator. Fluent’s proactive approach to compliance, coupled with its strategic partnerships and acquisitions, enables it to adapt to evolving regulatory landscapes while driving growth and profitability.
Strategic Vision
Fluent Corp’s strategic vision is centered on becoming a leading multi-state cannabis operator with a strong brand portfolio and a commitment to community engagement. The company’s recent rebranding and corporate name change reflect its alignment with its operational footprint and growth ambitions. Fluent continues to invest in its infrastructure, expand its retail presence, and enhance its product offerings to meet the needs of a diverse customer base. By prioritizing quality, innovation, and customer experience, Fluent aims to build long-term value for its stakeholders.
Cansortium Inc. (CSE: TIUM.U, OTCQB: CNTMF) has agreed to issue 143,678 common shares, valued at U.S. $0.87 each, to an independent director in exchange for canceling $125,000 in director fees. This transaction is classified as a related party transaction under MI 61-101, as it does not exceed 25% of the company's market capitalization. The company intends to expedite the transaction to reduce accrued liabilities. Debt Shares issued to Canadian residents will be subject to a four-month hold period, emphasizing Cansortium's commitment to financial efficiency.
Cansortium Inc. announced a rescheduled annual general and special meeting for shareholders on June 30, 2021, at 10:00 a.m. Toronto Time. This change follows shareholder feedback and adds two nominees for the board election, John McKimm and Alex Spiro, increasing the total nominees to six. The company also confirmed that two current directors, Neal Hochberg and David Abrams, will not seek re-election. Shareholders must disregard previous voting instructions and submit new ones using updated proxy forms. Further details will be available in a Supplement posted on SEDAR.
Cansortium Inc. (OTCQB: CNTMF) reported a 49% YoY increase in Q1 revenue, totaling $15.1 million, accompanied by a significant rise in adjusted EBITDA to $4.4 million. Florida revenue surged by 41.4% to $13.1 million. Despite a net loss of $5.1 million, a notable improvement from a prior loss of $13.9 million was recorded. The company anticipates expansion to 30 dispensaries and 150,000 ft² cultivation capacity by year-end, aiming for 2021 revenues of $90 million to $100 million.
Cansortium Inc. will hold a conference call on May 28, 2021, at 4:30 p.m. Eastern time to discuss its financial results for Q1 2021, ended March 31.
Details for participation include a toll-free number at 1-800-319-4610 and an international dial-in at (604) 638-5340. The call is an opportunity for management to address questions post-discussion.
Cansortium, operating under the Fluent™ brand, focuses on quality cannabis production and has licenses in Florida, Pennsylvania, Michigan, and Texas.
Cansortium Inc. (OTCQB: CNTMF) has redeemed up to US$5 million of its convertible promissory notes, reducing the total outstanding amount to US$5 million. These notes were initially issued for a total of US$10 million in February 2019. The remaining notes are due on December 1, 2022, unless converted at a price of US$0.60 per share. CEO Robert Beasley noted that this move represents an improvement in the company's balance sheet and its ongoing partnership with noteholders as Cansortium expands its operations in Florida and other markets.
Cansortium Inc. has announced it has satisfied its obligations under a US$12.9 million promissory note, originally due on December 1, 2022, owed to Can Endeavour LLC. The principal was converted into 21,555,483 common shares at a conversion price of US$0.60 per share. All accrued interest has been paid in cash. This note was tied to the acquisition of Fluent Servicing, LLC in August 2018. The common shares are unregistered under U.S. securities laws. Cansortium is focused on operational excellence in the cannabis sector, primarily in Florida.
Cansortium reports a Q4 revenue increase of 54% to $14.7 million and an adjusted EBITDA of $3.3 million. For the full year 2020, revenue surged by 84% to $52.4 million, with Florida revenue also up 84% to $46.4 million. The company anticipates 2021 revenue between $90 million and $100 million, driven by expansion in Florida and Pennsylvania. They achieved record sales of approximately $5 million in Florida in April 2021.
Cansortium Inc. announced the completion of a US$71 million Senior Secured Term Loan due April 2025, enhancing the company's liquidity and extending debt maturities. The loan, with an interest rate of 13%, will allow Cansortium to repay existing debts, including $27.1 million in convertible debentures, and significantly improve its balance sheet by adding over $40 million in cash. The funds will support expansion in Florida, Pennsylvania, and Michigan, where the company aims to capitalize on growth opportunities.
Cansortium announced the closing of its private placement, raising a total of US$17.1 million. The second closing contributed US$5.2 million at a unit price of US$0.70 per unit, consisting of a common share and half a warrant. Funds will be directed towards expanding operations in Florida and Michigan, including completing the Sweetwater cultivation facility's Phase 2, increasing production capacity, and opening new dispensaries. Cansortium aims to enhance its presence in the cannabis market, focusing on high-quality production and operational excellence.
Cansortium has successfully completed a US$12 million private placement, increasing the initial US$10 million target due to strong investor interest. Each unit comprises one common share and one-half warrant, exercisable at US$0.90 for 24 months. Proceeds will enhance cultivation capacity in Florida and expand operations in Michigan. Key initiatives include boosting annual flower production capacity from 3,000 lbs. to 6,000 lbs. and accelerating the opening of four new dispensaries. This financial milestone aims to create significant shareholder value.
FAQ
What is the current stock price of Fluent (CNTMF)?
What is the market cap of Fluent (CNTMF)?
What does Fluent Corp (CNTMF) do?
Where does Fluent Corp operate?
What is Fluent Corp's business model?
What makes Fluent Corp unique in the cannabis industry?
What are Fluent Corp's key product offerings?
Is Fluent Corp involved in both medical and adult-use cannabis markets?
How does Fluent Corp ensure product quality?
What is Fluent Corp's growth strategy?
What is the significance of Fluent Corp's recent rebranding?
How does Fluent Corp navigate regulatory challenges in the cannabis industry?
